Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D004348:Drug Labeling; D005260:Female; D006801:Humans; D007880:Legislation, Drug; D011247:Pregnancy; D012306:Risk; D013723:Teratogens; D014481:United States; D014486:United States Food and Drug Administration
D013723:Teratogens